Kanada - enska - Health Canada

pharmascience inc - quinapril (quinapril hydrochloride) - tablet - 10mg - quinapril (quinapril hydrochloride) 10mg - angiotensin-converting enzyme inhibitors

Kanada - enska - Health Canada

pharmascience inc - quinapril (quinapril hydrochloride) - tablet - 20mg - quinapril (quinapril hydrochloride) 20mg - angiotensin-converting enzyme inhibitors

Kanada - enska - Health Canada

pharmascience inc - quinapril (quinapril hydrochloride) - tablet - 40mg - quinapril (quinapril hydrochloride) 40mg - angiotensin-converting enzyme inhibitors

Bandaríkin - enska - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - quinapril hydrochloride (unii: 33067b3n2m) (quinaprilat - unii:34ssx5lde5) - quinapril 20 mg - hypertension quinapril tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with quinapril tablets, usp. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, d

Bandaríkin - enska - NLM (National Library of Medicine)

proficient rx lp - quinapril hydrochloride (unii: 33067b3n2m) (quinaprilat - unii:34ssx5lde5) - quinapril 10 mg - hypertension quinapril tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with quinapril tablets, usp. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, d

Bandaríkin - enska - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - quinapril hydrochloride (unii: 33067b3n2m) (quinaprilat - unii:34ssx5lde5) - quinapril 20 mg - hypertension quinapril tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with quinapril tablets, usp. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention,

Bandaríkin - enska - NLM (National Library of Medicine)

aurobindo pharma limited - quinapril hydrochloride (unii: 33067b3n2m) (quinaprilat - unii:34ssx5lde5) - quinapril 5 mg - hypertension quinapril tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with quinapril tablets, usp. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, d

Kanada - enska - Health Canada

auro pharma inc - quinapril (quinapril hydrochloride); hydrochlorothiazide - tablet - 10mg; 12.5mg - quinapril (quinapril hydrochloride) 10mg; hydrochlorothiazide 12.5mg - angiotensin-converting enzyme inhibitors

Kanada - enska - Health Canada

auro pharma inc - quinapril (quinapril hydrochloride); hydrochlorothiazide - tablet - 20mg; 12.5mg - quinapril (quinapril hydrochloride) 20mg; hydrochlorothiazide 12.5mg - angiotensin-converting enzyme inhibitors

Kanada - enska - Health Canada

auro pharma inc - quinapril (quinapril hydrochloride); hydrochlorothiazide - tablet - 20mg; 25mg - quinapril (quinapril hydrochloride) 20mg; hydrochlorothiazide 25mg - angiotensin-converting enzyme inhibitors